[go: up one dir, main page]

ES8400449A1 - Procedimiento para la preparacion de 10-(1,2-propadienil)es-teroides - Google Patents

Procedimiento para la preparacion de 10-(1,2-propadienil)es-teroides

Info

Publication number
ES8400449A1
ES8400449A1 ES503451A ES503451A ES8400449A1 ES 8400449 A1 ES8400449 A1 ES 8400449A1 ES 503451 A ES503451 A ES 503451A ES 503451 A ES503451 A ES 503451A ES 8400449 A1 ES8400449 A1 ES 8400449A1
Authority
ES
Spain
Prior art keywords
procedure
compound
preparation
insaturation
lithium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES503451A
Other languages
English (en)
Other versions
ES503451A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Merrell Dow Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharmaceuticals Inc filed Critical Merrell Dow Pharmaceuticals Inc
Publication of ES8400449A1 publication Critical patent/ES8400449A1/es
Publication of ES503451A0 publication Critical patent/ES503451A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0011—Androstane derivatives substituted in position 17 by a keto group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0018—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
    • C07J1/0022—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005—Ketals
    • C07J21/008—Ketals at position 17
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

PROCEDIMIENTO PARA LA PREPARACION DE 10-(1,2-PROPADIENIL) ESTEROIDES.CONSISTE EN SOMETER UN COMPUESTO DE HIDROZIPROPINILO (II) O (III) A UN PROCEDIMIENTO SELECCIONADO ENTRE: A) CONVERSION AL ACETATO CON ANHIDRIDO ACETICO SEGUIDO DE TRATAMIENTO CON LITIO-ALQUINILO-ALQUIL -COBRE O LITIO-DIMETIL COBRE TRASLADANDO A CONTINUACION CUALQUIER INSATURACION 5 A LA POSICION 4. B) OPCIONALMENTE, TRATAR EL PRODUCTO OBTENIDO (I) CON UN AGENTE DE DESHIDROGENACION PARA INTRODUCIR UNA INSATURACION EN EL NUCLEO DE ESTEROIDE. C) OPCIONALMENTE REDUCIR EL COMPUESTO PARA DAR EL COMPUESTO 17B-HIDROXI O TRATARLOCON UN DERIVADO ACIDO PARA DAR EL CORRESPONDIENTE 17B-ESTER.INHIBIDORES IRREVERSIBLES DE ENZIMAS DE AROMATASA.
ES503451A 1980-06-27 1981-06-26 Procedimiento para la preparacion de 10-(1,2-propadienil)es-teroides Granted ES503451A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/163,453 US4289762A (en) 1980-06-27 1980-06-27 10-(1,2-Propadienyl) steroids as irreversible aromatase inhibitors

Publications (2)

Publication Number Publication Date
ES8400449A1 true ES8400449A1 (es) 1983-11-01
ES503451A0 ES503451A0 (es) 1983-11-01

Family

ID=22590073

Family Applications (1)

Application Number Title Priority Date Filing Date
ES503451A Granted ES503451A0 (es) 1980-06-27 1981-06-26 Procedimiento para la preparacion de 10-(1,2-propadienil)es-teroides

Country Status (21)

Country Link
US (1) US4289762A (es)
JP (1) JPS5738798A (es)
AT (1) AT377989B (es)
AU (1) AU539215B2 (es)
BE (1) BE889404A (es)
CA (1) CA1173432A (es)
CH (1) CH647532A5 (es)
DE (1) DE3124719C2 (es)
DK (1) DK163129C (es)
ES (1) ES503451A0 (es)
FR (1) FR2485544A1 (es)
GB (1) GB2078750B (es)
IE (1) IE51352B1 (es)
IL (1) IL63142A0 (es)
IT (1) IT1171340B (es)
NL (1) NL8103098A (es)
NO (1) NO156694C (es)
NZ (1) NZ197495A (es)
PH (1) PH16690A (es)
SE (1) SE448878B (es)
ZA (1) ZA814219B (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0100566B1 (en) * 1982-07-14 1986-02-19 Akzo N.V. Novel 19-thio-androstane derivatives
US4495102A (en) * 1982-09-03 1985-01-22 G. D. Searle & Co. Aminoalkyl steroids
EP0114033B1 (de) * 1982-12-21 1988-10-12 Ciba-Geigy Ag Substituierte Azabicycloalkane, ihre Verwendung, pharmazeutische Präparate, welche diese Verbindungen enthalten, und Verfahren zur Herstellung dieser Verbindungen
DE3323321A1 (de) * 1983-06-24 1985-01-03 Schering AG, 1000 Berlin und 4709 Bergkamen Prophylaxe und therapie von koronaren herzkrankheiten durch senkung des oestrogenspiegels
US4634694A (en) * 1984-01-14 1987-01-06 Akzo N.V. Novel Δ4 - and Δ5 -androstene derivatives and pharmaceutical compositions containing these derivatives
GB8531747D0 (en) * 1985-12-24 1986-02-05 Erba Farmitalia 10beta-alkynylestrene derivatives
GB8624251D0 (en) * 1986-10-09 1986-11-12 Erba Farmitalia "1,2-beta-methylene-4-substituted androstene-3,17 dione derivatives
DE3705990A1 (de) * 1987-02-20 1988-09-01 Schering Ag 1-methyl-15(alpha)-(1-oxyalkyl)-androsta-1,4-dien- 3,17-dione, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate
DE3714965A1 (de) * 1987-04-30 1988-11-10 Schering Ag 3-methylen-4-androsten-17-one, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate
US4910191A (en) * 1988-06-28 1990-03-20 Merrell Dow Pharmaceuticals Inc. 19-substituted progesterone derivatives useful as 19-hydroxylase inhibitors
CH683151A5 (de) * 1991-04-24 1994-01-31 Ciba Geigy Ag Antikonzeption bei weiblichen Primaten ohne Beeinflussung des menstruellen Zyklus.
DE4435368A1 (de) * 1994-09-22 1996-03-28 Schering Ag Verwendung von Aromatasehemmern zur Herstellung eines Arzneimittels zur Behandlung eines relativen Androgenmangels beim Mann
WO1996024123A1 (en) 1995-02-01 1996-08-08 Seiko Epson Corporation Liquid crystal display device, method of its driving and methods of its inspection
ES2283541T3 (es) * 2001-04-17 2007-11-01 Ares Trading S.A. Inhibicion de aromatasa para mejorar el indice de implantacion.
DE10141937A1 (de) * 2001-08-28 2003-03-27 Alfred Schmidt Markierung der Aromatase
EP1854465A1 (en) * 2006-05-12 2007-11-14 Alexander Tobias Teichmann Use of 4,17 beta-dihydroxyandrost-4-ene-3-one for treating cancers
CA2794565C (en) 2010-04-08 2018-08-21 Emory University Substituted androst-4-ene diones
EP3666276A1 (en) 2018-12-14 2020-06-17 dcic Biopharmaceutical Limited Medication against estrogen-receptor beta (erbeta) positive breast tumor

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3102127A (en) * 1962-06-12 1963-08-27 Syntex Corp 19-methylene-androstane derivatives
FR1519387A (fr) * 1966-04-20 1968-03-29 Hoffmann La Roche Procédé pour la préparation de 19-alcényl-stéroïdes
DE2310963A1 (de) * 1972-04-14 1974-09-05 Schering Ag Methode zur kontrazeption durch verabfolgung von stufenkombinationspraeparaten
CH606101A5 (es) * 1975-01-30 1978-10-13 Ciba Geigy Ag

Also Published As

Publication number Publication date
AU539215B2 (en) 1984-09-13
IT1171340B (it) 1987-06-10
NL8103098A (nl) 1982-01-18
US4289762A (en) 1981-09-15
IE811435L (en) 1981-12-27
AT377989B (de) 1985-05-28
IL63142A0 (en) 1981-09-13
CH647532A5 (de) 1985-01-31
SE8103988L (sv) 1981-12-28
NO812509L (no) 1983-01-24
IE51352B1 (en) 1986-12-10
GB2078750B (en) 1984-08-22
DK163129B (da) 1992-01-20
DK163129C (da) 1992-06-09
IT8148781A1 (it) 1982-12-26
CA1173432A (en) 1984-08-28
SE448878B (sv) 1987-03-23
GB2078750A (en) 1982-01-13
JPS5738798A (en) 1982-03-03
FR2485544A1 (fr) 1981-12-31
AU7236981A (en) 1982-01-07
IT8148781A0 (it) 1981-06-26
PH16690A (en) 1984-01-06
DK284481A (da) 1981-12-28
NO156694C (no) 1987-11-04
NZ197495A (en) 1985-01-31
ES503451A0 (es) 1983-11-01
DE3124719A1 (de) 1982-03-18
ZA814219B (en) 1982-07-28
FR2485544B1 (es) 1983-12-16
ATA285881A (de) 1984-10-15
NO156694B (no) 1987-07-27
BE889404A (fr) 1981-12-28
JPH0121158B2 (es) 1989-04-19
DE3124719C2 (de) 1994-03-03

Similar Documents

Publication Publication Date Title
ES8400449A1 (es) Procedimiento para la preparacion de 10-(1,2-propadienil)es-teroides
IE831483L (en) Triphenylimidazole derivatives
AU523428B2 (en) Process of strengthening dilute phosphoric acid
ES484901A1 (es) Procedimiento para la obtencion de esteres de acido 3-cloro-estiril-2,2-dimetil-cilopropancarboxilico de accion ectopa- rasiticida
JPS5257130A (en) Process for preparation of methylphenols
JPS51122056A (en) Steroid carboxylic acid and derivatives thereof
JPS5273825A (en) Preparation of organic phosphorous compounds
GB1487544A (en) Dermatological composition
JPS52106857A (en) Preparation of 1,3-disubstituted-2-azetidinones
AU503014B2 (en) Organic (thio) phosphoric acid esters
JPS5231094A (en) Preparation of cephalexin
JPS51125376A (en) Process for preparing urea clathrate compounds of ascorbic acid deriva tives
JPS5246018A (en) Process for preparation of farnesyl acetates
JPS52111587A (en) Preparation of 6-aminopenam carboxylic acid-1-oxide or its derivatives
JPS5256193A (en) Process for copolyesterpolyol
JPS527950A (en) Preparation of ursodeoxycholic acid
JPS5398918A (en) Preparation of gamma-pyrone derivatives
JPS5271489A (en) Synthesis of josamycin derivative
JPS5257114A (en) Process for ether-containing acrylic acid ester or methacrylic acid es ter
JPS523061A (en) Process for preparing 4-cyanoimidazole-5-carbamic acid esters
ZA792822B (en) Process for the preparation of cyclohexane-1,3-diones from delta-ketocarboxylic acid esters
JPS5246014A (en) Process for preparation of gamma-unsaturated carboxylic acid esters
JPS52142089A (en) Preparation of cephalosporanic acid derivatives
DE3362239D1 (en) Process for preparing 3-alpha,7-beta-dihydroxy-5-beta-cholanic acid
ES393227A1 (es) Un procedimiento para la preparacion del compuesto 1,2-alfa-metilen - 6,7 - alfa - difluormetilen - 20 - espirox - 4 - en-3-ona.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970519